Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002799.SZ
Valuation Bad
0%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -0.76 1.56 1.57
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 97.09 -4.80 -165.15
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.97 4.22 4.18
Cash -10.60 1.57 1.75
Capex 40.76 -0.18 -0.30
Free Cash Flow 41.60 -0.09 -0.15
Revenue 20.09 1.38 1.15
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 129.67 0.14 0.06
Operating Margin -92.72 0.06 -0.87
ROA -91.37 0.01 -0.12
ROE -91.54 0.02 -0.20
ROIC -92.56 0.01 -0.19
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002799.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002799.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002799.SZ is permitted for members.